21 May 2018
A new public-private partnership launches to improve clinical trial infrastructure and facilitate new medicines for children in Europe
Members of the conect4children (c4c) initiative have launched a large collaborative paediatric network to facilitate the development of new drugs and other therapies for the entire paediatric population in Europe. The conect4children (collaborative network for European clinical trials for children) consortium aims to enhance the competitiveness of Europe for developing medicines for children by using existing expertise, patient access and developing common processes to be applied to disease natural history studies, registries, studies of new therapies, and comparisons of existing therapies.
This consortium is a novel collaboration between academic and private sectors that includes 33 academic and 10 industry partners from 20 European countries, more than 50 third parties and around 500 affiliated partners. The six-year project, comprised of a multidisciplinary public-private consortium, brings together key stakeholders across academia and industry. It is a pioneering opportunity to build capacity for the management of multinational paediatric clinical trials across Europe while ensuring the voices of children, young people, and their families are heard.
Read the full press release under conect4children.org